Tandem Diabetes Care (TNDM) Interest & Investment Income (2013 - 2025)

Tandem Diabetes Care (TNDM) has reported Interest & Investment Income for 13 consecutive years, with $4.2 million the latest figure, recorded in Q1 2025.

• For the quarter ending Q1 2025, Interest & Investment Income fell 21.1% year-over-year to $4.2 million; the trailing twelve-month figure through Mar 2025 stood at $16.9 million (down 24.36% YoY), and the FY2024 full-year result was $18.0 million, down 21.28% from the prior year.
• Interest & Investment Income slipped to $4.2 million in Q1 2025 per TNDM's latest filing, from $4.5 million in the prior quarter.
• Across five years, Interest & Investment Income topped out at $5.9 million in Q1 2023 and bottomed at -$47000.0 in Q4 2021.
• Historically, Interest & Investment Income has averaged $3.0 million across 5 years, with a median of $3.1 million in 2022.
• The sharpest annual moves came in 2021 and 2022: Interest & Investment Income slumped 114.16% in 2021, then surged 6687.23% in 2022.
• Over 5 years, Interest & Investment Income stood at -$47000.0 in 2021, then soared by 6687.23% to $3.1 million in 2022, then jumped by 79.36% to $5.6 million in 2023, then declined by 18.76% to $4.5 million in 2024, then declined by 7.05% to $4.2 million in 2025.
• According to Business Quant data, Interest & Investment Income over the past three periods registered $4.2 million, $4.5 million, and $5.3 million for Q1 2025, Q4 2024, and Q3 2024 respectively.